B+
Bull case
20%
Probability
Target price
$108.00
+71.9% vs current
GEHC
GE HealthcareBNasdaq / Health Care Equipment & Services
Last Price
At close
2026-07-20
AI scenario view
RankAlpha Sentiment AIMost likely
B
Base case
60%
Probability
Target price
$91.20
+45.2% vs current
B-
Bear case
20%
Probability
Target price
$73.00
+16.2% vs current
AI sentiment snapshot
Latest data as of 2026-01-08
Recent news sentiment (30D)
+30.0
Positive
Company
-
Unavailable
Macro
+30.0
Positive
Pulse
-
Unavailable
Sentiment proxy
+87.5
Score
AI commentary
Cautiously constructive: analyst midpoints cluster near $90–91, limiting near-term upside versus the anchor; dispersion (highs to $108, lows to $73) reflects execution sensitivity. Market focus is on order trends, service revenue growth, and upcoming guidance, with sentiment toggling on quarterly results and execution cues [#SERP-1][#SERP-4].
RankAlpha Sentiment AI - 2026-01-08
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-04-08eventNext quarterly earnings (estimated)High impact
Next quarterly report (date estimated) — earnings vs. consensus and guidance revision likely to drive near‑term volatility; date assumed per conservative 90‑day rule when not disclosed [#SERP-8].
2026-04-08catalystAnalyst target revisions / consensus updatesMedium impact
Analyst coverage shows a clustered 12‑month consensus near the low‑to‑mid $90s; upgrades/downgrades from this set could move the stock in the short term [#SERP-1][#SERP-4].
2027-01-08catalystProduct adoption and backlog realizationHigh impact
Medium‑term revenue/EBITDA upside as installed base and new imaging/diagnostics offerings scale; impact is structural and assessed on a 12‑month horizon (assumed 365 days) [#SERP-3].
Recommendation
N/A
No formal recommendation provided.
As of 2026-01-08 • Updated nightlySource: Internal modelMethodology